Verici Dx plc (LSE: VRCI) Stock Analysis & Fundamentals | ScreenerHero

Create free account

VRCIVerici Dx plc

LSE · GB · Healthcare · Diagnostics & Research · vericidx.com

0.3500GBp0.00%Mkt Cap: 8.70M $P/E: —2d ago

Verici Dx plc, together with its subsidiary, Verici Dx Inc, develops prognostic and diagnostic tests for kidney transplant patients in the United Kingdom and the United States. The company develops Tutivia, a post-transp…

Industry Peers

Diagnostics & Research

Thermo Fisher Scientific Inc.

$201.86BUSDP/E 29.8

Danaher Corporation

$145.10BUSDP/E 39.7

$45.85BUSDP/E 44.2

IDEXX Laboratories, Inc.

$45.44BUSDP/E 42.4

Agilent Technologies, Inc.

$38.44BUSDP/E 27.3

Waters Corporation

$37.13BUSDP/E 48.1

IQVIA Holdings Inc.

$35.13BUSDP/E 26.2

$28.78BUSDP/E 34.6

Mettler-Toledo International Inc.

$26.98BUSDP/E 31.4

Quest Diagnostics Incorporated

$23.18BUSDP/E 23.1

Labcorp Holdings Inc.

$23.12BUSDP/E 25.0

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.36BUSDP/E 33.9

Eurofins Scientific SE

$13.06BUSDP/E 27.3

$12.46BUSDP/E 53.7

Charles River Laboratories International, Inc.

bioMérieux S.A.

$9.26BUSDP/E 21.6

BillionToOne, Inc.

$5.90BUSDP/E 237.4

Twist Bioscience Corporation

Sotera Health Company

$5.21BUSDP/E 44.6

$4.73BUSDP/E 54.8

DiaSorin S.p.A.

$3.75BUSDP/E 26.5

Adaptive Biotechnologies Corporation

NeoGenomics, Inc.

GeneDx Holdings Corp.

Vimian Group AB (publ)

$1.64BUSDP/E 41.7

Personalis, Inc.

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Clínica Baviera, S.A.

$1.02BUSDP/E 21.4

OPKO Health, Inc.

Castle Biosciences, Inc.

$616.40MUSDP/E 40.2

Myriad Genetics, Inc.

Fulgent Genetics, Inc.

$293.12MUSDP/E 2.9

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Scope Fluidics S.A.

Eurofins-Cerep SA

$89.37MUSDP/E 17.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

Proteome Sciences plc

ENDRA Life Sciences Inc.

Oxford BioDynamics Plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Leveljump Healthcare Corp.

Prostatype Genomics AB (publ)

Telo Genomics Corp.

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap8.70M $

Enterprise Value2.34M $

Revenue (TTM)3.98M $

Gross Profit3.08M $

Net Income (TTM)-7.54M $

Revenue/Share0.0054 USD

Last Price0.3500 GBp

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees18

CountryGB

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-0.34

EV/Revenue0.59

P/S2.18

P/B0.46

EPS (TTM)-0.01

EPS (Forward)0.00

52W Range

0.30005% of range1.250

52W High1.250 GBp

52W Low0.3000 GBp

Profitability

Gross Margin77.46%

Oper. Margin-221.13%

EBITDA Margin-174.78%

Profit Margin-189.22%

ROE-106.58%

ROA-87.32%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-8.98M $

CapEx (TTM)205.43K $

FCF Margin-159.53%

FCF Yield-73.01%

Net Debt-3.42M $

Net Debt/EBITDA0.49

Balance Sheet

Debt/Equity0.03

Current Ratio3.94

Quick Ratio3.61

Book Value/Sh0.0076 GBp

Cash/Share0.0020 GBp

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 GBp

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)2.900 GBp

Upside (mean)+728.6%

Target Range2.900 GBp – 2.900 GBp

# Analysts1

Ownership

Shares Out.2.29B

Float974.05M

Insiders2.56%

Institutions74.07%

Technical

SMA 500.3995 (-12.4%)

SMA 2000.6028 (-41.9%)

Beta1.26

S&P 52W Chg20.25%

Avg Vol (30d)1.77M

Avg Vol (10d)1.04M

Technical Indicators

RSI (14)11.9

MACD-0.0148

MACD Signal-0.0150

MACD Hist.+0.0002

BB Upper0.3910 GBp

BB Middle0.3675 GBp

BB Lower0.3440 GBp

BB Width12.79%

ATR (14)0.0514 GBp

Vol Ratio (20d)0.21x